Glycosyltransferases have attracted
increasing interest for the
ability to construct glycosylated molecules in a facile way. However,
promiscuous chemoselectivity and poor regioselectivity hinder their
widespread application in the synthetic field, especially in the pharmaceutical
area. Here, a plant glycosyltransferase, MiCGT, was engineered by
directed evolution to catalyze the glycosylation of flavonoids, which
opens the door to pharmaceutical applications. Combining an alanine
scan and iterative saturation mutagenesis, mutants with enhanced chemo-
and regioselectivity and significantly improved activities toward
seven different flavonoids were evolved, and two glycosylated products
were prepared on a large scale. The best quadruple mutant VFAH enables
strict 3-O glycosylation selectivity and a 120-fold activity enhancement
toward the model substrate quercetin relative to the wild type (WT).
Moreover, the crystal structures of the WT and mutant VFAH were obtained,
a breakthrough of its kind in plant glycosyltransferase research.
The origin of substrate specificity and regioselectivity was elucidated
by combining the experimental data with the unique structure information.
We anticipate that this work will aid future protein engineering of
this type of enzyme.